These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25395461)

  • 1. Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.
    Ruan Y; Kovalchuk A; Jayanthan A; Lun X; Nagashima Y; Kovalchuk O; Wright JR; Pinto A; Kirton A; Anderson R; Narendran A
    Neuro Oncol; 2015 Jun; 17(6):822-31. PubMed ID: 25395461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.
    Küsters-Vandevelde HV; Willemsen AE; Groenen PJ; Küsters B; Lammens M; Wesseling P; Djafarihamedani M; Rijntjes J; Delye H; Willemsen MA; van Herpen CM; Blokx WA
    Acta Neuropathol Commun; 2014 Apr; 2():41. PubMed ID: 24713450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
    Mitre V; Heym K; Clark GD; Venkatramani R
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
    Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
    Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hydrocephalus caused by diffuse leptomeningeal and neurocutaneous melanocytosis of antenatal onset: a clinical, pathologic, and molecular study of 2 cases.
    Uguen A; Laurent C; Samaison L; Boisselier B; Talagas M; Costa S; Aziza J; Mokhtari K; Le Maréchal C; Marcorelles P
    Hum Pathol; 2015 Aug; 46(8):1189-96. PubMed ID: 26037215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?
    Patel J; Salgado CM; Múgica MR; Basu D
    Neuro Oncol; 2016 Jan; 18(1):142-3. PubMed ID: 26667139
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to "Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?".
    Ruan Y; Narendran A
    Neuro Oncol; 2016 Jan; 18(1):143-4. PubMed ID: 26667140
    [No Abstract]   [Full Text] [Related]  

  • 8. Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway.
    Basu D; Salgado CM; Bauer BS; Johnson D; Rundell V; Nikiforova M; Khakoo Y; Gunwaldt LJ; Panigrahy A; Reyes-Múgica M
    Neuro Oncol; 2016 Apr; 18(4):528-37. PubMed ID: 26354928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocutaneous melanocytosis (melanosis).
    Ruggieri M; Polizzi A; Catanzaro S; Bianco ML; Praticò AD; Di Rocco C
    Childs Nerv Syst; 2020 Oct; 36(10):2571-2596. PubMed ID: 33048248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
    Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
    Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large congenital melanocytic nevi and neurocutaneous melanocytosis: one pediatric center's experience.
    Lovett A; Maari C; Decarie JC; Marcoux D; McCuaig C; Hatami A; Savard P; Powell J
    J Am Acad Dermatol; 2009 Nov; 61(5):766-74. PubMed ID: 19766348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRAS
    Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
    Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis.
    Takahashi H; Natsumeda M; Hara N; Koyama A; Shimizu H; Miyashita A; Satake D; Mouri Y; Tsukano J; Kawabe K; Tsukamoto Y; Okada M; Ogura R; Yuki A; Umezu H; Kakita A; Ikeuchi T; Oishi M
    Acta Neuropathol Commun; 2024 Jan; 12(1):14. PubMed ID: 38254245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi.
    Gerami P; Paller AS
    J Invest Dermatol; 2013 Sep; 133(9):2127-30. PubMed ID: 23949765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
    Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
    J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocutaneous melanosis presenting with hydrocephalus. Case report and review of the literature.
    Acosta FL; Binder DK; Barkovich AJ; Frieden IJ; Gupta N
    J Neurosurg; 2005 Jan; 102(1 Suppl):96-100. PubMed ID: 16206742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A newborn with neurocutaneous melanocytosis and Dandy-Walker malformation.
    De Cock J; Snauwaert J; Van Rompaey W; Morren MA; Demaerel P
    Pediatr Neurol; 2014 Mar; 50(3):276-8. PubMed ID: 24321541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurosurgical management of patients with neurocutaneous melanosis: a systematic review.
    Rahman RK; Majmundar N; Ghani H; San A; Koirala M; Gajjar AA; Pappert A; Mazzola CA
    Neurosurg Focus; 2022 May; 52(5):E8. PubMed ID: 35535823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
    Kolin DL; Geddie WR; Ko HM
    Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurocutaneous melanosis: follow-up and literature review.
    Scattolin MA; Lin J; Peruchi MM; Rocha AJ; Masruha MR; Vilanova LC
    J Neuroradiol; 2011 Dec; 38(5):313-8. PubMed ID: 21489630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.